Manual, intermittent readings
Nurses measure drain output on 4–8 hour intervals, introducing variability and long blind periods between checks, including overnight.
4–8hBetween readings
Clip-on sensors that continuously measure volume, flow rate, color, and turbidity, streaming data to a secure dashboard, auto-charting to the EHR, and predicting optimal drain-removal timing.
Post-operative surgical drains are still read by eye, written by hand, and second-guessed by clinical experience. That gap costs hospitals time, patients comfort, and care teams confidence.
Nurses measure drain output on 4–8 hour intervals, introducing variability and long blind periods between checks, including overnight.
Color and turbidity, key indicators of infection, chyle, or bile leak, are judged by the naked eye, with no audit trail or objective trend line.
Without continuous trending, drains stay in 1–3 days longer than needed, increasing infection risk, readmission rates, and length of stay.
FlowMo is a clip-on sensor module that attaches to the existing drain line, with no changes to surgical workflow. It streams four validated signals to a clinician-facing dashboard and directly into the EHR.
Non-invasive measurement of drained volume and flow rate at 4 Hz — bench-validated to ±0.1 mL accuracy across physiologic ranges.
Inline optical sensing distinguishes serous, sanguineous, bilious, and chylous effluents — and flags sudden changes indicative of infection or leak.
Bedside and remote views for the care team, with configurable thresholds, trends, and audit-ready event logs.
Auto-charts via HL7 and FHIR, with no manual entry, no transcription errors, and a predictive model that suggests optimal removal timing.
FlowMo targets the surgical specialties where drain output directly drives clinical decisions, and where continuous, objective data changes care.
Early identification of anastomotic leak via volume, color, and turbidity shifts in Jackson-Pratt or Blake drains.
Objective trending of chest-tube drainage to support safe, timely removal decisions post-cardiac or thoracic surgery.
Continuous home monitoring replaces patient-reported logs, improving compliance and surgeon confidence at clinic visits.
Turbidity + color sensing catches bilious changes that standard volume-only tracking routinely misses.
FlowMo has been vetted by medical faculty, design competitions, and IP review, with progress on the fundamentals of a clinical-grade medical device.
Selected as a Legacy Team for the 6th Annual NEOvations Bench to Bedside Competition at Northeast Ohio Medical University, presenting FlowMo's prototype and delivering a live elevator pitch to a panel of judges.
Covering sensor architecture, signal processing, and the predictive drain-removal model. Patent Pending.
Bench-tested through multiple hardware revisions, including sensor calibration, enclosure fit, and end-to-end telemetry to the dashboard validated in lab conditions.
Guidance from partner physicians who inform clinical design and validation, alongside startup advisors helping navigate FDA clearance, fundraising, and go-to-market strategy.
A small, technical team building FlowMo out of Virginia, guided by academic physicians and industry scientists.
Leads overall strategy, clinical research, and trial design. Deep learning and LLM experience with peer-reviewed publications and national presentations.
Drives product vision. Focuses on rural health innovation and AI-powered clinical decision support.
Medical student managing physician outreach, partnership development, and day-to-day operations.
Develops sensors, firmware, and device case. Full-stack developer and systems engineer who holds multiple patents.
Runs operations and engineering integration. Full-stack developer managing 13 clinical trials; founded VAROS Technologies and Vexa Research.
A staged roadmap from functional prototype to clinical deployment, with clear technical and regulatory milestones.
Functional Wound-Reel hardware, end-to-end telemetry, and sensor accuracy validated in lab conditions.
Engaging physicians as clinical advisors and securing letters of intent from potential hospital customers to validate market demand.
Class II medical device that is 510(k) exempt and follows General Controls, including FDA registration, device listing, and Quality System (QSR) compliance.
Hospital pilots in the operating room and other settings, paired with EHR integration rollout.
Selected mentions and appearances. Reach out for press inquiries or to feature FlowMo.
Presented a working prototype and live elevator pitch to a panel of judges at Northeast Ohio Medical University.
Covering continuous drain-fluid telemetry and the predictive drain-removal model.
Pitch deck and technical brief available to accredited investors, hospital partners, and strategic advisors.
Milestones, lab updates, and open roles as we scale from prototype to pilot.